
Sigma Healthcare Abandons $10bn Pursuit of UK Retail Chain Boots
Australian pharmaceutical group Sigma Healthcare has dropped its $10bn pursuit of UK retail chain Boots, stating the deal would not meet its strategic and capital investment objectives. The withdrawal extends uncertainty for the 177-year-old chain, which was put up for sale in 2022. Sigma shares rose 6% on the news.










